According to Rospotrebnadzor, clinical trials of the drug are coming to an end. It is planned to start production in 2023.
Rotavirus is an acute intestinal infection that can be contracted at any age, but children from 1.5 to 2 years old are most often infected.
As of today, vaccination against rotavirus infection is included in the national vaccination calendar according to epidemiological indications.
